{"id":"https://openalex.org/W266561510","doi":"https://doi.org/10.1371/journal.pone.0126867","title":"Conventional Chemotherapy and Oncogenic Pathway Targeting in Ovarian Carcinosarcoma Using a Patient-Derived Tumorgraft","display_name":"Conventional Chemotherapy and Oncogenic Pathway Targeting in Ovarian Carcinosarcoma Using a Patient-Derived Tumorgraft","publication_year":2015,"publication_date":"2015-05-11","ids":{"openalex":"https://openalex.org/W266561510","doi":"https://doi.org/10.1371/journal.pone.0126867","mag":"266561510","pmid":"https://pubmed.ncbi.nlm.nih.gov/25962155","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4427104"},"language":"en","primary_location":{"id":"doi:10.1371/journal.pone.0126867","doi":"https://doi.org/10.1371/journal.pone.0126867","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0126867","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0126867&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0126867&type=printable","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052515933","display_name":"Gretchen Elizabeth Glaser","orcid":"https://orcid.org/0000-0001-9413-316X","observed_orcids":["https://orcid.org/0000-0001-9413-316X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gretchen Glaser","raw_affiliation_strings":["Division of Gynecologic Surgery, Mayo Clinic, Rochester, MN, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Gynecologic Surgery, Mayo Clinic, Rochester, MN, United States of America","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088406750","display_name":"S. John Weroha","orcid":"https://orcid.org/0000-0002-7130-7259","observed_orcids":["https://orcid.org/0000-0002-7130-7259"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"S. John Weroha","raw_affiliation_strings":["Department of Oncology, Mayo Clinic, Rochester, MN, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Mayo Clinic, Rochester, MN, United States of America","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106615740","display_name":"Marc A. Becker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marc A. Becker","raw_affiliation_strings":["Department of Oncology, Mayo Clinic, Rochester, MN, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Mayo Clinic, Rochester, MN, United States of America","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112318039","display_name":"Xiaonan Hou","orcid":"https://orcid.org/0000-0002-9406-4747","observed_orcids":["https://orcid.org/0000-0002-9406-4747"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaonan Hou","raw_affiliation_strings":["Department of Oncology, Mayo Clinic, Rochester, MN, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Mayo Clinic, Rochester, MN, United States of America","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072533667","display_name":"Sergio Enderica-Gonzalez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sergio Enderica-Gonzalez","raw_affiliation_strings":["Department of Oncology, Mayo Clinic, Rochester, MN, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Mayo Clinic, Rochester, MN, United States of America","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102960136","display_name":"Sean C. Harrington","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sean C. Harrington","raw_affiliation_strings":["Department of Oncology, Mayo Clinic, Rochester, MN, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Mayo Clinic, Rochester, MN, United States of America","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089153267","display_name":"Paul Haluska","orcid":"https://orcid.org/0000-0003-3283-4512","observed_orcids":["https://orcid.org/0000-0003-3283-4512"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Haluska","raw_affiliation_strings":["Department of Oncology, Mayo Clinic, Rochester, MN, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Mayo Clinic, Rochester, MN, United States of America","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5088406750"],"corresponding_institution_ids":["https://openalex.org/I1330342723"],"apc_list":{"value":2382,"currency":"USD","value_usd":2382},"apc_paid":{"value":2382,"currency":"USD","value_usd":2382},"fwci":3.0472,"has_fulltext":true,"cited_by_count":28,"citation_normalized_percentile":{"value":0.89602501,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"10","issue":"5","first_page":"e0126867","last_page":"e0126867"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ovarian-carcinosarcoma","display_name":"ovarian carcinosarcoma","score":1.0},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.9359999895095825},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.6330000162124634},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.7710000276565552},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ifosfamide","display_name":"ifosfamide","score":0.996999979019165},{"id":"https://openalex.org/keywords/egfr-overexpression","display_name":"EGFR overexpression","score":0.7820000052452087},{"id":"https://openalex.org/keywords/egfr-amplification","display_name":"EGFR amplification","score":0.871999979019165},{"id":"https://openalex.org/keywords/vegf-c","display_name":"VEGF-C","score":0.746999979019165},{"id":"https://openalex.org/keywords/irs-1","display_name":"IRS-1","score":0.9350000023841858},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.8140000104904175},{"id":"https://openalex.org/keywords/insulin-like-growth-factor-pathway","display_name":"insulin-like growth factor pathway","score":0.9200000166893005},{"id":"https://openalex.org/keywords/pan-her-inhibitor","display_name":"pan-HER inhibitor","score":0.6819999814033508},{"id":"https://openalex.org/keywords/vegf-inhibitors","display_name":"VEGF inhibitors","score":0.9330000281333923},{"id":"https://openalex.org/keywords/igf1r-inhibitors","display_name":"IGF1R inhibitors","score":0.9179999828338623},{"id":"https://openalex.org/keywords/kras-mutation","display_name":"KRAS mutation","score":0.9800000190734863},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.8989999890327454},{"id":"https://openalex.org/keywords/pik3ca-mutation","display_name":"PIK3CA mutation","score":0.984000027179718},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.7689999938011169},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.7680000066757202},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.8769999742507935}],"concepts":[{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.8882431983947754},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.7485612630844116},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.6657705307006836},{"id":"https://openalex.org/C2778938455","wikidata":"https://www.wikidata.org/wiki/Q5038170","display_name":"Carcinosarcoma","level":3,"score":0.6361526846885681},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6100524663925171},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.600216269493103},{"id":"https://openalex.org/C2777506904","wikidata":"https://www.wikidata.org/wiki/Q418560","display_name":"Ifosfamide","level":4,"score":0.5221489071846008},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.49008047580718994},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4653084874153137},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4643654525279999},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4361334443092346},{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.4166608154773712},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.32129883766174316},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.2094382643699646},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.14580705761909485},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.10701850056648254},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.08369854092597961},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07192561030387878}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002296","descriptor_name":"Carcinosarcoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002296","descriptor_name":"Carcinosarcoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D002296","descriptor_name":"Carcinosarcoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002296","descriptor_name":"Carcinosarcoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016190","descriptor_name":"Carboplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016190","descriptor_name":"Carboplatin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020869","descriptor_name":"Gene Expression Profiling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047368","descriptor_name":"Tumor Burden","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1371/journal.pone.0126867","doi":"https://doi.org/10.1371/journal.pone.0126867","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0126867","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0126867&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4427104","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4427104","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS One","raw_type":"Text"},{"id":"pmid:25962155","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25962155","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PloS one","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:997ac478d98d4010b051ed4a6c94333d","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/997ac478d98d4010b051ed4a6c94333d","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PLoS ONE, Vol 10, Iss 5, p e0126867 (2015)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1371/journal.pone.0126867","doi":"https://doi.org/10.1371/journal.pone.0126867","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0126867","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0126867&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.75,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000230084","display_name":null,"funder_award_id":"CA136393","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000871886","display_name":"Diabetes and Metabolism","funder_award_id":"T32DK007352","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G9000909664","display_name":"Mayo Clinic Ovarian Cancer SPORE","funder_award_id":"P50CA136393","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337357","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W266561510.pdf","grobid_xml":"https://content.openalex.org/works/W266561510.grobid-xml"},"referenced_works_count":53,"referenced_works":["https://openalex.org/W167805848","https://openalex.org/W1975107689","https://openalex.org/W1981421409","https://openalex.org/W1983882083","https://openalex.org/W1991396678","https://openalex.org/W1992750800","https://openalex.org/W1993199678","https://openalex.org/W1995515978","https://openalex.org/W2011967800","https://openalex.org/W2016180830","https://openalex.org/W2020240832","https://openalex.org/W2030818757","https://openalex.org/W2045147591","https://openalex.org/W2046551180","https://openalex.org/W2046807777","https://openalex.org/W2047518202","https://openalex.org/W2047811624","https://openalex.org/W2054383376","https://openalex.org/W2060968328","https://openalex.org/W2062919736","https://openalex.org/W2065335064","https://openalex.org/W2072176789","https://openalex.org/W2089911218","https://openalex.org/W2095680943","https://openalex.org/W2098900183","https://openalex.org/W2099063182","https://openalex.org/W2099540110","https://openalex.org/W2106157865","https://openalex.org/W2108234281","https://openalex.org/W2108976255","https://openalex.org/W2110017381","https://openalex.org/W2113122060","https://openalex.org/W2117964602","https://openalex.org/W2121019919","https://openalex.org/W2122074718","https://openalex.org/W2122737206","https://openalex.org/W2127998852","https://openalex.org/W2128746885","https://openalex.org/W2129105829","https://openalex.org/W2131100943","https://openalex.org/W2131564505","https://openalex.org/W2135947389","https://openalex.org/W2137988182","https://openalex.org/W2139580868","https://openalex.org/W2142851253","https://openalex.org/W2147619880","https://openalex.org/W2148861440","https://openalex.org/W2155851270","https://openalex.org/W2164928932","https://openalex.org/W2182182388","https://openalex.org/W2332396504","https://openalex.org/W2468960578","https://openalex.org/W4238747939"],"related_works":["https://openalex.org/W2786222180","https://openalex.org/W2249883256","https://openalex.org/W7118878557","https://openalex.org/W3083534491","https://openalex.org/W4297147379","https://openalex.org/W2902825151","https://openalex.org/W2900268715","https://openalex.org/W2497581391","https://openalex.org/W4388850056","https://openalex.org/W2007192772"],"abstract_inverted_index":{"Ovarian":[0],"carcinosarcoma":[1,58,219],"is":[2,60],"a":[3,136,158],"rare":[4],"subtype":[5],"of":[6,16,51,86,116,239],"ovarian":[7,57,182,218],"cancer":[8,183],"with":[9,39,131,133,172,185],"poor":[10],"clinical":[11,23],"outcomes.":[12],"The":[13,82],"low":[14],"incidence":[15],"this":[17,217],"disease":[18],"makes":[19],"accrual":[20],"to":[21,66,71,78,122,125,196,214,230,233],"large":[22],"trials":[24],"challenging.":[25],"However,":[26],"studies":[27],"have":[28,179,197],"shown":[29],"that":[30],"treatment":[31],"responses":[32,41],"in":[33,42,181,205,216],"patient-derived":[34],"xenograft":[35],"(PDX)":[36],"models":[37],"correlate":[38],"matched-patient":[40],"the":[43,72,127,166],"clinic,":[44],"supporting":[45],"their":[46],"use":[47],"for":[48],"preclinical":[49],"testing":[50],"standard":[52],"and":[53,63,68,80,89,106,118,138,186,207,221],"novel":[54],"therapies.":[55],"An":[56],"PDX":[59,83,128,220],"presented":[61],"herein":[62],"showed":[64],"resistance":[65],"carboplatin":[67],"paclitaxel":[69],"(similar":[70],"patient)":[73],"but":[74,142,194],"exhibited":[75],"significant":[76],"sensitivity":[77],"ifosfamide":[79],"paclitaxel.":[81],"demonstrated":[84],"overexpression":[85,115,223],"EGFR":[87,100],"mRNA":[88],"gene":[90,222],"amplification":[91,225],"by":[92,114,157],"array":[93],"comparative":[94],"genomic":[95],"hybridization":[96],"(log2":[97],"ratio":[98],"0.399).":[99],"phosphorylation":[101],"was":[102,129,144,162,170,191,212,227],"also":[103,112,163,192,203],"detected.":[104],"Angiogensis":[105],"insulin-like":[107],"growth":[108,147],"factor":[109],"pathways":[110],"were":[111,202],"implicated":[113],"VEGFC":[117],"IRS1.":[119],"In":[120,209],"order":[121],"improve":[123],"response":[124,232,240],"chemotherapy,":[126],"treated":[130],"carboplatin/paclitaxel":[132,215],"or":[134,149,224],"without":[135,187],"pan-HER":[137],"VEGF":[139],"inhibitor":[140,168],"(BMS-690514)":[141],"there":[143],"no":[145,198],"tumor":[146],"inhibition":[148],"improved":[150],"animal":[151],"survival,":[152],"which":[153],"may":[154],"be":[155],"explained":[156],"KRAS":[159],"mutation.":[160],"Resistance":[161],"observed":[164],"when":[165],"IGF-1R":[167],"BMS-754807":[169],"combined":[171],"carboplatin/paclitaxel.":[173],"Because":[174],"poly":[175],"(ADP-ribose)":[176],"polymerase":[177],"inhibitors":[178],"activity":[180],"patients,":[184],"BRCA":[188],"mutations,":[189],"ABT-888":[190],"tested":[193],"found":[195],"activity.":[199],"Pathogenic":[200],"mutations":[201],"detected":[204],"TP53":[206],"PIK3CA.":[208],"conclusion,":[210],"ifosfamide/paclitaxel":[211],"superior":[213],"alone":[226],"not":[228],"sufficient":[229],"predict":[231],"targeted":[234],"therapy.":[235],"Better":[236],"predictive":[237],"markers":[238],"are":[241],"needed.":[242]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":4},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}